Melanie Watson

669 total citations
16 papers, 503 citations indexed

About

Melanie Watson is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Melanie Watson has authored 16 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Hematology. Recurrent topics in Melanie Watson's work include Multiple Myeloma Research and Treatments (6 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Protein Degradation and Inhibitors (4 papers). Melanie Watson is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Protein Degradation and Inhibitors (4 papers). Melanie Watson collaborates with scholars based in United States, United Kingdom and Australia. Melanie Watson's co-authors include Maia Parsadanian, Steven M. Paul, Anne M. Fagan, Kelly R. Bales, David M. Holtzman, Mitsunori Yamada, Elliott Richelson, J. D. Briggs, Ajay K. Nooka and A. Graham Wilkinson and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Melanie Watson

16 papers receiving 486 citations

Peers

Melanie Watson

PHYSI

CMN

ONCOL

SURGE

Ting Huang China

Ting Lin China

H.‐C. Lam Taiwan

Ryan S. Tonkin Australia

Tianpeng Zheng China

Olga Kastsiuchenka Italy

Ulrika Krus Sweden

Tamar Guetta‐Baranes United Kingdom

Chih-Chieh Mao Taiwan

Alina González‐Quevedo Cuba

Ting Huang China

Melanie Watson

150 ×0.6

PHYSI

194 ×1.1

53 ×0.5

CMN

116 ×1.5

ONCOL

36 ×0.5

SURGE

Citations per year, relative to Melanie Watson Melanie Watson (= 1×) peers Ting Huang

Countries citing papers authored by Melanie Watson

Since Specialization

Citations

This map shows the geographic impact of Melanie Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Watson more than expected).

Fields of papers citing papers by Melanie Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Watson. The network helps show where Melanie Watson may publish in the future.

Co-authorship network of co-authors of Melanie Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Watson. A scholar is included among the top collaborators of Melanie Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Watson. Melanie Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Nooka, Ajay K., et al.. (2018). Managing Infusion Reactions to New Monoclonal Antibodies in Multiple Myeloma: Daratumumab and Elotuzumab. Journal of Oncology Practice. 14(7). 414–422. 27 indexed citations

Kaufman, Jonathan L., Charise Gleason, Lawrence Boise, et al.. (2014). Bortezomib in Combination with Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin (V-DCEP) for the Treatment of Multiple Myeloma. Blood. 124(21). 2139–2139. 10 indexed citations

Gleason, Charise, Jonathan L. Kaufman, Ajay K. Nooka, et al.. (2014). Vorinostat, Bortezomib, Cyclophosphomide, Thalidomide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients. Blood. 124(21). 5773–5773. 1 indexed citations

Watson, Melanie, et al.. (2014). Colesevelam Hydrochloride for the Treatment of Lenalidomide Induced Diarrhea. Blood. 124(21). 5779–5779. 4 indexed citations

Nooka, Ajay K., Amelia Langston, Edmund K. Waller, et al.. (2013). Early versus delayed autologous stem cell transplant (ASCT) in patients receiving induction therapy with lenalidomide, bortezomib, and dexamethasone (RVD) for newly diagnosed multiple myeloma (MM).. Journal of Clinical Oncology. 31(15_suppl). 8540–8540. 2 indexed citations

Nooka, Ajay K., Amelia Langston, Charise Gleason, et al.. (2012). Impact of Body Mass Index (BMI) On Overall Survival in Myeloma. Blood. 120(21). 4289–4289. 4 indexed citations

Nooka, Ajay K., Madhusmita Behera, Lawrence Boise, et al.. (2011). Thalidomide As Maintenance Therapy in Multiple Myeloma (MM) Improves Progression Free Survival (PFS) and Overall Survival (OS): A Meta-Analysis. Blood. 118(21). 1855–1855. 8 indexed citations

Fagan, Anne M., Jennie Taylor, Maia Parsadanian, et al.. (2004). ApoAI Deficiency Results in Marked Reductions in Plasma Cholesterol But No Alterations in Amyloid-β Pathology in a Mouse Model of Alzheimer's Disease-Like Cerebral Amyloidosis. American Journal Of Pathology. 165(4). 1413–1422. 46 indexed citations

Fagan, Anne M., Melanie Watson, Maia Parsadanian, et al.. (2002). Human and Murine ApoE Markedly Alters Aβ Metabolism before and after Plaque Formation in a Mouse Model of Alzheimer's Disease. Neurobiology of Disease. 9(3). 305–318. 235 indexed citations

10.

Findlay, Christine, et al.. (2000). Children of renal transplant recipient mothers. Journal of Paediatrics and Child Health. 36(3). 230–235. 49 indexed citations

11.

Jardine, Alan G., et al.. (2000). Cardiac and vascular abnormalities in renal transplant patients: differential effects of cyclosporin and azathioprine.. PubMed. 13(3). 185–92. 23 indexed citations

12.

Rowe, P. A., Melanie Watson, Margaret McMillan, et al.. (1994). Prospective randomised study of the influence of cyclosporin on long-term renal allograft function.. PubMed. 26(5). 2617–8. 1 indexed citations

13.

Yamada, Mitsunori, et al.. (1994). Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells.. Molecular Pharmacology. 46(3). 470–476. 46 indexed citations

14.

Tsakiris, Dimitrios, Melanie Watson, Dimitrios Degiannis, J. D. Briggs, & B. J. R. Junor. (1987). Association between blood transfusion, HLA-DRW6, and response to dinitrochlorobenzene skin test.. PubMed. 19(1 Pt 1). 705–7. 1 indexed citations

15.

Bradley, J. Andrew, et al.. (1987). Low-dose cyclosporine or azathioprine one year after renal transplantation.. PubMed. 19(1 Pt 3). 1858–9. 4 indexed citations

16.

Watson, Melanie, et al.. (1979). ENDOGENOUS CELL-MEDIATED IMMUNITY, BLOOD TRANSFUSION, AND OUTCOME OF RENAL TRANSPLANTATION. The Lancet. 314(8156-8157). 1323–1326. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact